Resurgent air travel and a strategic acquisition helped SATS climb over 100 places in the Fortune Southeast Asia 500

Chinese biotech challenges Eli Lilly's obesity drug dominance as the pharma giant anticipates new trial results, while Emcure expands its portfolio with a major stake in Zuventus, signaling industry consolidation.
All major sources, one page
Feel the mood behind headlines
Know what’s trending, globally
Get summaries. Save time
8,462
150
211
an hour ago
Get instant summaries, explore trending stories, and dive deeper into the headlines — all in one sleek, noise-free mobile experience.
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more
All major sources, one page
Feel the mood behind headlines
Know what’s trending, globally
Get summaries. Save time
8,462
150
211
an hour ago
Get instant summaries, explore trending stories, and dive deeper into the headlines — all in one sleek, noise-free mobile experience.
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more